General methods for selectively incorporating unnatural amino acids into proteins in vivo, directly from the growth media, would greatly expand our ability to manipulate protein structure and function.
General methods for selectively incorporating unnatural amino acids into proteins in vivo, directly from the growth media, would greatly expand our ability to manipulate protein structure and function.
1 For example, the ability to place fluorophores selectively into proteins in vivo would provide powerful tools for cell biology, or the ability to generate large quantities of proteins with metal binding or keto amino acids might lead to proteins with enhanced physical or catalytic properties. Our approach involves the generation of a suppressor tRNA/aminoacyl-tRNA synthetase (tRNA CUA /aaRS) pair that is orthogonal to Escherichia coli endogenous tRNA/synthetase pairs; that is, the orthogonal tRNA is not a substrate for any endogenous synthetases and the orthogonal synthetase does not recognize any endogenous tRNAs.
2,3
The specificity of this synthetase is then altered so that it charges the tRNA CUA only with a desired unnatural amino acid. One such orthogonal pair for use in E. coli was developed from the tRNA 2 Gln /GlnRS pair from Saccharomyces cereVisiae. 3 The development of additional orthogonal tRNA/aaRS pairs may allow the simultaneous incorporation of multiple unnatural amino acids into proteins. Moreover, different aminoacyl synthetases may be better starting points for generating active sites with particular specificities (e.g., specificity for large hydrophobic vs small hydrophilic amino acids). To this end, we have analyzed biochemical data available for tRNA Tyr /TyrRS pairs from a variety of organisms. This analysis, together with in vivo complementation assays, has afforded a new orthogonal tRNA CUA Tyr /TyrRS pair as well as insights into the development of additional pairs.
The identity elements of prokaryotic tRNA Tyr include a long variable arm in contrast to the short arm of eukaryotic tRNA Tyr . 4 In addition, eukaryotic tRNA Tyr contains a C1:G72 positive recognition element, whereas prokaryotic tRNA Tyr has no such consensus base pair. 5, 6 In vitro studies have also shown that tRNA Tyr of S. cereVisiae 7 and Homo sapiens 8 cannot be aminoacylated by bacterial synthetases, nor do their TyrRS aminoacylate bacterial tRNA. To test whether tRNA CUA Tyr /TyrRS pairs from these organisms are orthogonal in E. coli, an in vivo complementation assay was used that is based on suppression of an amber stop codon in a nonessential position of the TEM-1 -lactmase gene encoded in plasmid pBLAM.
3 If the newly introduced suppressor tRNA CUA is aminoacylated by any endogenous E. coli synthetases, cells will grow in the presence of ampicillin. After expressing these tRNA CUA Tyr in E. coli strain DH10B transformed with pBLAM, cells survive at very high concentrations of ampicillin, greater than 1206 µg/mL (interpolated from IC 50 curves in Figure 1 ) for tRNA CUA Tyr derived from S. cereVisiae and 234 µg/mL for that from H. sapiens. When S. cereVisiae tRNA CUA Gln , which is an orthogonal tRNA, is tested under the same conditions, the cells survive at only 20 µg/mL ampicillin.
3 For comparison, E. coli strains bearing pBLAM alone survive up to 9.7 µg/mL ampicillin (in the absence of any suppressor tRNA). Since the recognition of tRNA by synthetase depends on relative concentrations in the cell, 9,10 the concentration of tRNA CUA Tyr was decreased by expressing its gene under the weaker lac promoter instead of the strong lpp promoter. The IC 50 's decreased to 383 and 84 µg/ mL ampicillin for S. cereVisiae and H. sapiens, respectively, but these values are still potentially too high to allow the use of these tRNAs in orthogonal pairs.
The change of one single nucleotide in the anticodon (G34 to C34) made the S. cereVisiae and H. sapiens tRNA Tyr susceptible to acylation by the E. coli synthetases. Most tRNAs have positive and negative elements in the acceptor and anticodon domains to ensure accurate aminoacylation.
11,12 Once the anticodon is changed from GUA to CUA, it is possible that noncognate synthetases that recognize tRNAs with similar anticodons have a stronger affinity for tRNA CUA Tyr . We hypothesized that the introduction of In vivo complementation assays to determine the orthogonality of tRNA CUA Tyr 's from various organisms expressed in E. coli. pAC-XYCUA was used to express tRNA CUA Tyr of organism X under the control of the lpp promoter where X ) Y is S. cereVisiae, X ) H is H. sapiens and X ) J is M. jannaschii. pAC-lacXYCUA is similar to pAC-XYCUA except the lpp promoter was changed to lac. pAC-supF was used to express E. coli supF tRNA. pAC is a control plasmid without any tRNA gene. pBLAM was used to express the -lactamase gene with an amber stop codon at Ala-184. pBLAM-XYRS encodes the indicated TyrRS gene. Numbers following legend text are IC50 values in units of µg/mL ampicillin.
additional negative recognition elements (with respect to E. coli synthetases) could restore orthogonality. To test this notion, C1: G72 of S. cereVisiae tRNA CUA Tyr was mutated to G1:C72. This tRNA CUA Tyr (C1G G72C) did show a much lower IC 50 (12.5 µg/mL ampicillin), indicating that it is a poorer substrate for the E. coli synthetases than S. cereVisiae tRNA CUA Gln . Unfortunately, this tRNA is no longer recognized by its cognate TyrRS from S. cereVisiae, since C1:G72 is a critical S. cereVisiae TyrRS positive determinant.
5 Because it is difficult to rationally design both negative and positive recognition elements into tRNAs, we searched for a tRNA with identity elements outside of the anticodon, in particular, the tRNA CUA Tyr /TyrRS pair from the archaebacterium Methanococcus jannaschii. This Tyr aminoacyl synthetase is missing most of the nonconserved domain binding to the anticodon loop of its tRNA
Tyr , but has the CP1 insertion in the active site to discriminate C1:G72 from G1:C72. Thus, the M. jannaschii TyrRS aminoacylates S. cereVisiae but not E. coli crude tRNA. 13 The properties of M. jannaschii TyrRS suggested it should act as an orthogonal TyrRS in E. coli, and furthermore, that its cognate tRNA Tyr may be a good candidate for an orthogonal tRNA CUA .
To test this notion, M. jannaschii tRNA CUA Tyr was expressed in E. coli in the presence of pBLAM. The transformed cells survived at 55.5 µg/mL ampicillin. Coexpression of M. jannaschii tRNA CUA Tyr and TyrRS allowed cells to survive at 1220 µg/mL ampicillin, indicating TyrRS charges the tRNA CUA Tyr efficiently (compared to the natural suppressor tRNA supF for which the IC 50 is 1700 µg/mL ampicillin). This increase is not due to the aminoacylation by M. jannaschii TyrRS of any endogenous E. coli tRNAs since expression of M. jannaschii TyrRS alone (pAC + pBLAM-JYRS) afforded an IC 50 value similar to that of cells without any exogenous tRNA or TyrRS (pAC + pBLAM). On the basis of these assays, the M. jannaschii tRNA CUA Tyr /TyrRS pair appears to be a viable orthogonal pair in E. coli. The tRNA alone may be aminoacylated at a very low level by the E. coli synthetases, but coexpression of the M. jannaschii TyrRS is likely to compete with other E. coli endogenous synthetases and further reduce noncognate aminoacylation.
10
To further test the in vivo complementation results, tRNA CUA Tyr from different organisms was expressed alone or coexpressed with cognate TyrRS in the presence of the -galactosidase gene containing an amber codon at position 125 in E. coli strain CA274 (HfrC lac am125 trp am ). 14 Suppression of the amber codon produces functional -galactosidase, which turns cells blue in the presence of added X-Gal. As shown in Table 1 , transformants with IC 50 values higher than 84 µg/mL all turned blue. The -galactosidase activities measured by spectrophotometry also indicated that M. jannaschii tRNA CUA Tyr could suppress the amber codon at a low level due to charging by endogenous E. coli synthetases. Suppression is increased 22-fold with coexpression of the cognate TyrRS, which correlates with the in vivo complementation assay. It should be noted that the -galactosidase activities were not directly proportional to IC 50 values, presumably because the suppression of the amber codons in -lactamase and -galactosidase occurs in different sequence contexts and the two enzymes tolerate different amino acids to different extents at those positions. In contrast to the results of Ohno et al., 15 who reported that expression of S. cereVisiae tRNA CUA Tyr alone in CA274 gives white colonies and that S. cereVisiae tRNA CUA Tyr is not aminoacylated by E. coli synthetases, our result showed that colonies of CA274 with S. cereVisiae tRNA CUA Tyr expressed were clearly blue whenever the tRNA CUA Tyr gene is under control of lpp or lac promoter. Moreover, the -galactosidase activity is very high and is similar to that afforded by expression of the supF suppressor.
In conclusion, we have developed a new functional orthogonal tRNA CUA Tyr /TyrRS pair for use in E. coli by importing the M. jannaschii tRNA CUA Tyr /TyrRS pair into E. coli. In contrast, neither of the Tyr amber suppressor tRNA derived from human nor yeast tRNAs were orthogonal to the E. coli synthetases, and while a mutant of the yeast amber suppressor is orthogonal, it is no longer recognized by its cognate yeast synthetase. Although the M. jannaschii tRNA CUA Tyr is somewhat "less orthogonal" than the yeast tRNA CUA Gln we previously developed, 3 the M. jannaschii synthetase has higher aminoacylation activity toward its cognate tRNA. We therefore view this pair as a promising candidate for the next stage of this overall strategy, which involves modification of the amino acid specificity of the synthetase. Figure 1 for plasmid definition. pBR-XYRS was used to express TyrRS of organism X and pBR was the control plasmid lacking TyrRS. b Transformed E. coli cells were plated on LB plates containing 35 µg/mL chloramphenicol, 100 µg/mL ampicillin, 0.5 mM IPTG, and 0.004% (w/v) X-Gal. The plates were incubated at 37°C overnight. c -galactosidase activity was measured with the high sensitivity -galactosidase assay protocol of Stratagene. Total protein was measured with the Coomassie Plus protein assay reagent of Pierce. One unit of -galactosidase converts 1 nmol of chlorophenol red--D-galactopyranoside to chlorophenol red and galactose in 1 min at 37°C
.
